Jeil Bio, Vaccine/Diagnostic Reagents/Quarantine (Novel Flu, AI, etc.) Theme Rises 5.08% ↑

On the 14th, the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) theme rose by 3.13% compared to the previous day, showing strength, while Jeil Bio, a related stock attracting attention, surged by 5.08% compared to the previous day. Jeil Bio is known as a manufacturer specializing in veterinary pharmaceuticals.

[Graph] Major stock price changes in the vaccine/diagnostic reagent/quarantine (novel flu, AI, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Bio’s quant financial score is 24.96 points, with higher stability and profitability scores than the average of other stocks related to the vaccine/diagnostic reagent/quarantine (novel flu, AI, etc.) theme, but its quant financial ranking was only 23rd out of 43 stocks. On the other hand, Kolmar Holdings ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.